Peter Ernster
Chairman of the Board of Directors
Ronald H. Goldfarb, Ph.D.
Sopherion Therapeutics, Inc.
Director
Christopher Moller, Ph.D.
TL Ventures
Director
James Niedel, M.D., Ph.D.
New Leaf Venture Partners
Director
Marc J. Ostro, Ph.D.
TL Ventures
Director
Seth A. Rudnick, M.D.
Canaan Partners
Director
Joyce Tsang, Ph.D.
ProQuest Investments
Director
Donald Yarson
Genzyme General
Director
